ASX Announcement Change of Company Address Melbourne, Australia; 23 October 2026: Starpharma (ASX: SPL, US OTC: SPHRY) today advises that effective from Monday 26 October 2026, its registered office, principal place of business, and postal addresses will change as follows: To Suite 3.02, Level 3,...
Details of Company Address
Filed with ASX · · 1 page · English
Summary by 6ix AI
Starpharma Holdings Limited has announced a change of company address. This change will take effect from a specified date in late October. The address change also applies to Starpharma's Australian subsidiary, Starpharma Pty Ltd.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Starpharma Holdings Limited on 6ix
Story so far
Earlier from Starpharma
- Quarterly Activities/Appendix 4C Cash Flow Report
- $3.5 Million R&D Tax Incentive Received
- Starpharma Investor Presentation Petalion Webinar
- Starpharma secures majority ownership of Petalion
- Trading Halt
Later from Starpharma
- Application for quotation of securities - SPL
- Becoming a substantial holder
- AGM Chair address and CEO presentation
- Results of 2026 Annual General Meeting
- Chair and Deputy Chair Appointments
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma